Structures by: Xie Y. S.
Total: 35
C23H17NO3
C23H17NO3
Chemical communications (Cambridge, England) (2020) 56, 13 1948-1951
a=13.0762(14)Å b=6.6583(7)Å c=21.175(2)Å
α=90° β=106.715(2)° γ=90°
C84H69Cl6Cu6N21
C84H69Cl6Cu6N21
RSC Advances (2013) 3, 39 18134
a=29.024(3)Å b=29.024(3)Å c=11.2581(11)Å
α=90.00° β=90.00° γ=120.00°
C30H32Cl2Cu2N6O2S2
C30H32Cl2Cu2N6O2S2
RSC Advances (2013) 3, 39 18134
a=10.7383(12)Å b=15.1497(16)Å c=10.7339(11)Å
α=90.00° β=117.9710(10)° γ=90.00°
C26H20CuIN6
C26H20CuIN6
RSC Advances (2013) 3, 39 18134
a=7.6592(10)Å b=14.6130(17)Å c=20.536(2)Å
α=90.00° β=93.1880(10)° γ=90.00°
C30H24N6O8Zn2
C30H24N6O8Zn2
RSC Advances (2013) 3, 39 18134
a=10.7980(11)Å b=9.0501(9)Å c=15.7801(15)Å
α=90.00° β=102.5500(10)° γ=90.00°
C52H44Ag4N24O2
C52H44Ag4N24O2
RSC Advances (2013) 3, 39 18134
a=11.1740(12)Å b=15.3189(17)Å c=15.2751(15)Å
α=90.00° β=93.7650(10)° γ=90.00°
C60H73Co4N10O30S4
C60H73Co4N10O30S4
RSC Advances (2013) 3, 39 18134
a=12.2383(11)Å b=12.2768(12)Å c=14.7929(16)Å
α=109.411(2)° β=108.631(2)° γ=98.7100(10)°
C32H38CuN6O8
C32H38CuN6O8
RSC Advances (2013) 3, 39 18134
a=7.01610(10)Å b=7.86470(10)Å c=15.6706(2)Å
α=79.5240(10)° β=78.1340(10)° γ=67.6390(10)°
C22H20FeN4O3
C22H20FeN4O3
Dalton transactions (Cambridge, England : 2003) (2007) 31 3390-3397
a=10.7467(15)Å b=8.6769(12)Å c=11.5977(16)Å
α=90.00° β=115.636(2)° γ=90.00°
C92H92Cl4Cu2Fe4N16O30
C92H92Cl4Cu2Fe4N16O30
Dalton transactions (Cambridge, England : 2003) (2007) 31 3390-3397
a=17.4718(13)Å b=22.0788(16)Å c=51.605(4)Å
α=90.00° β=90.00° γ=90.00°
C88H76Cl4Fe4N16Ni2O22
C88H76Cl4Fe4N16Ni2O22
Dalton transactions (Cambridge, England : 2003) (2007) 31 3390-3397
a=18.45(2)Å b=22.31(2)Å c=54.77(7)Å
α=90.00° β=90.00° γ=90.00°
C46H46Cl2CoFeN8O13
C46H46Cl2CoFeN8O13
Dalton transactions (Cambridge, England : 2003) (2007) 31 3390-3397
a=17.9062(8)Å b=21.4295(9)Å c=53.006(2)Å
α=90.00° β=90.00° γ=90.00°
C25H38ClCoN4O11
C25H38ClCoN4O11
CrystEngComm (2012) 14, 21 7312
a=12.9687(12)Å b=7.9248(7)Å c=14.4847(14)Å
α=90.00° β=106.2220(10)° γ=90.00°
C70H112Cl2Cu8N22O28S6
C70H112Cl2Cu8N22O28S6
CrystEngComm (2012) 14, 21 7312
a=27.5390(9)Å b=27.5390(9)Å c=13.4753(8)Å
α=90.00° β=90.00° γ=90.00°
C15.5H28Cl2N4NiO11.5
C15.5H28Cl2N4NiO11.5
CrystEngComm (2012) 14, 21 7312
a=17.6242(12)Å b=11.8799(8)Å c=11.8432(8)Å
α=90.00° β=108.9330(10)° γ=90.00°
C38.5H58ClN11Ni4O7.5S3
C38.5H58ClN11Ni4O7.5S3
CrystEngComm (2012) 14, 21 7312
a=15.1068(16)Å b=17.4396(18)Å c=20.834(2)Å
α=90.00° β=92.0550(10)° γ=90.00°
Ethyl 1-(2-bromoethyl)-3-ferrocenyl-1H-pyrazole-5-carboxylate
C18H19BrFeN2O2
Acta Crystallographica Section E (2007) 63, 4 m978-m979
a=17.8019(13)Å b=9.4929(6)Å c=10.3623(7)Å
α=90.00° β=94.130(5)° γ=90.00°
C21H17FeN3OS
C21H17FeN3OS
Acta Crystallographica Section C (2002) 58, 1 m43-m44
a=12.95190(10)Å b=18.14060(10)Å c=15.6117(2)Å
α=90.00° β=95.2300(10)° γ=90.00°
9-<i>O</i>-Butylberberrubinium bromide
C23H24NO4,Br
Acta Crystallographica Section E (2009) 65, 6 o1370
a=9.716(4)Å b=7.623(3)Å c=27.443(11)Å
α=90.00° β=92.983(8)° γ=90.00°
<i>N</i>-Benzyl-2-(2-chloro-5-methylphenoxy)acetamide
C16H16ClNO2
Acta Crystallographica Section E (2008) 64, 12 o2426
a=9.5549(18)Å b=11.086(2)Å c=14.725(3)Å
α=71.747(4)° β=89.062(4)° γ=85.655(4)°
6-Chloro-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-one
C8H6ClNO2
Acta Crystallographica Section E (2008) 64, 12 o2369
a=4.5359(6)Å b=7.7000(10)Å c=21.281(3)Å
α=90.00° β=90.00° γ=90.00°
4-Benzyl-7-chloro-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-one
C15H12ClNO2
Acta Crystallographica Section E (2009) 65, 5 o1019
a=5.0894(11)Å b=12.630(3)Å c=20.070(4)Å
α=90.00° β=91.833(4)° γ=90.00°
1-(4-<i>tert</i>-Butylbenzyl)-3-phenyl-1<i>H</i>-pyrazole-5-carboxylic acid
C21H22N2O2
Acta Crystallographica Section E (2009) 65, 6 o1273
a=12.336(2)Å b=17.632(3)Å c=8.7876(17)Å
α=90.00° β=97.910(3)° γ=90.00°
2-(4-Chlorophenyl)-5-(3,4-dimethoxyphenethyl)-6,7-dihydropyrazolo[1,5- <i>a</i>]pyrazin-4(5<i>H</i>)-one
C22H22ClN3O3
Acta Crystallographica Section E (2009) 65, 7 o1457
a=7.1709(4)Å b=10.6982(5)Å c=13.9169(6)Å
α=81.156(3)° β=77.150(2)° γ=72.278(2)°
4-(<i>o</i>-Tolylamino)benzaldehyde
C14H13NO
Acta Crystallographica Section E (2010) 66, 11 o2827
a=14.193(10)Å b=10.699(10)Å c=7.677(6)Å
α=90.00° β=90.00° γ=90.00°
2-[5-(1,3-Benzodioxol-5-yl)-3-ferrocenyl-4,5-dihydro-1<i>H</i>- pyrazol-1-yl]-4-phenyl-1,3-thiazole
C29H23FeN3O2S
Acta Crystallographica Section E (2010) 66, 10 m1275
a=10.228(5)Å b=11.018(5)Å c=12.604(6)Å
α=107.776(8)° β=100.416(8)° γ=112.767(7)°
4-(<i>p</i>-Tolylamino)benzaldehyde
C14H13NO
Acta Crystallographica Section E (2010) 66, 11 o2828
a=5.8356(12)Å b=8.2581(18)Å c=24.137(5)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2,4-Dichloro-6-{1-[(2-chloroethyl)imino]ethyl}phenol
C10H10Cl3NO
Acta Crystallographica Section E (2010) 66, 12 o3106
a=14.5710(2)Å b=10.2323(2)Å c=7.73840(10)Å
α=90.00° β=94.3760(10)° γ=90.00°
C12.5H10.5Br2CdN3.5O0.5
C12.5H10.5Br2CdN3.5O0.5
Crystal Growth & Design (2006) 6, 6 1341
a=17.180(3)Å b=15.269(3)Å c=12.1374(19)Å
α=90.00° β=108.606(3)° γ=90.00°
C25H19Cl4N7O0Zn2
C25H19Cl4N7O0Zn2
Crystal Growth & Design (2006) 6, 6 1341
a=15.875(2)Å b=15.131(2)Å c=12.1758(16)Å
α=90.00° β=110.960(2)° γ=90.00°
C25H19Cd2I4N7O0
C25H19Cd2I4N7O0
Crystal Growth & Design (2006) 6, 6 1341
a=17.360(9)Å b=15.178(8)Å c=24.457(13)Å
α=90.00° β=90.00° γ=90.00°
C25H19Cl4Hg2N7O0
C25H19Cl4Hg2N7O0
Crystal Growth & Design (2006) 6, 6 1341
a=16.7768(12)Å b=14.4667(10)Å c=23.5340(16)Å
α=90.00° β=90.00° γ=90.00°
C25H19Hg2I4N7O0
C25H19Hg2I4N7O0
Crystal Growth & Design (2006) 6, 6 1341
a=17.755(3)Å b=15.139(3)Å c=24.304(5)Å
α=90.00° β=90.00° γ=90.00°
C12.5H10.5CdCl2N3.5O0.5
C12.5H10.5CdCl2N3.5O0.5
Crystal Growth & Design (2006) 6, 6 1341
a=17.0876(17)Å b=14.9487(15)Å c=12.0009(12)Å
α=90.00° β=109.473(2)° γ=90.00°
C25H19Br4Hg2N7O0
C25H19Br4Hg2N7O0
Crystal Growth & Design (2006) 6, 6 1341
a=17.1651(8)Å b=14.7379(7)Å c=23.6550(11)Å
α=90.00° β=90.00° γ=90.00°